Literature DB >> 7558448

Cancer in the African population of Harare, Zimbabwe, 1990-1992.

M T Bassett1, E Chokunonga, B Mauchaza, L Levy, J Ferlay, D M Parkin.   

Abstract

The data presented from the population-based cancer registry in Harare, Zimbabwe, represent the first information on the incidence of cancer in Southern Africa for almost 20 years. In the African population in Zimbabwe there are several features in common with other countries in sub-Saharan Africa: high rates of liver, prostate and cervix cancer, low rates of large-bowel cancer and breast cancer. Also, as reported from southern and south-eastern Africa, there are relatively high incidence rates of cancers of the oesophagus, bladder and (in men) lung. The AIDS epidemic has given rise to a striking increase in incidence of Kaposi's sarcoma (now the commonest cancer of African men), but there is not much evidence for an increase in incidence of non-Hodgkin lymphomas nor, although rates are very high, of cervical cancer.

Entities:  

Mesh:

Year:  1995        PMID: 7558448     DOI: 10.1002/ijc.2910630107

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  19 in total

1.  The pursuit of equity in health: reflections on race and public health data in Southern Africa.

Authors:  M T Bassett
Journal:  Am J Public Health       Date:  2000-11       Impact factor: 9.308

2.  Kaposi's sarcoma: a 10-year experience with 248 patients at a single tertiary care hospital in Tanzania.

Authors:  Phillipo L Chalya; Fidelis Mbunda; Peter F Rambau; Hyasinta Jaka; Nestory Masalu; Mariam Mirambo; Martha F Mushi; Samuel E Kalluvya
Journal:  BMC Res Notes       Date:  2015-09-15

Review 3.  Epidemiology and pathogenesis of Kaposi's sarcoma-associated herpesvirus.

Authors:  C Boshoff; R A Weiss
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2001-04-29       Impact factor: 6.237

Review 4.  Systematic review: epidemiology of oesophageal cancer in Sub-Saharan Africa.

Authors:  Rabson Kachala
Journal:  Malawi Med J       Date:  2010-09       Impact factor: 0.875

Review 5.  Prospects of a novel vaccination strategy for human gamma-herpesviruses.

Authors:  Ting-Ting Wu; Marcia A Blackman; Ren Sun
Journal:  Immunol Res       Date:  2010-12       Impact factor: 2.829

6.  Trends of Kaposi's sarcoma at AIDS diagnosis in Europe and the United States, 1987-94.

Authors:  S Franceschi; L Dal Maso; A Lo Re; D Serraino; C La Vecchia
Journal:  Br J Cancer       Date:  1997       Impact factor: 7.640

7.  Kaposi's sarcoma-associated herpesvirus latency-associated nuclear antigen 1 mimics Epstein-Barr virus EBNA1 immune evasion through central repeat domain effects on protein processing.

Authors:  Hyun Jin Kwun; Suzane Ramos da Silva; Ishita M Shah; Neil Blake; Patrick S Moore; Yuan Chang
Journal:  J Virol       Date:  2007-05-23       Impact factor: 5.103

Review 8.  Kaposi's sarcoma-associated herpesvirus immunoevasion and tumorigenesis: two sides of the same coin?

Authors:  Patrick S Moore; Yuan Chang
Journal:  Annu Rev Microbiol       Date:  2003       Impact factor: 15.500

9.  Trends and Histopathological Patterns of Kaposi Sarcoma at The University of Benin Teaching Hospital, Benin City, Nigeria.

Authors:  Gerald Dafe Forae; Darlington Ewaen Obaseki
Journal:  Oman Med J       Date:  2018-07

10.  Estimating the incidence of colorectal cancer in Sub-Saharan Africa: A systematic analysis.

Authors:  Alice Graham; Davies Adeloye; Liz Grant; Evropi Theodoratou; Harry Campbell
Journal:  J Glob Health       Date:  2012-12       Impact factor: 4.413

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.